DoW Alzheimer’s Transforming Care Award

The FY26 Alzheimer’s Transforming Care Award supports clinical research and clinical trials on interventions, innovations, and solutions for dementia care for people with Alzheimer’s disease and related dementias and their care partners. Eligible applicants include U.S. Department of War organizations and other U.S. organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; awards go to organizations, not individuals. The program expects to fund about three awards with roughly $5.4 million total, with a maximum of $1.6 million in total costs for a single-PI application or $1.9 million combined for the CIT Partnership Option, over up to 4 years. Cost sharing is not required. Community collaboration is required for studies that prospectively enroll human subjects, and clinical trials that only test or evaluate pharmacological interventions, animal studies, and travel beyond the stated meeting limits are not allowed.

✳ AI-generated summary — verify against the announcement

• Science and Technology and other Research and Development
• Research & Discovery
• Older Adults & Family Caregivers
• Patients & People with Health Conditions
• Aging, Dementia & Caregiving
• Biomedical & Disease Research

• ✓ Unrestricted